A group of researchers has found a new way to limit excessive immune responses, which may point in a new direction for research in and treatment of e.g. autoimmune diseases.
Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV. A group of transmitter substances (cytokines) in the immune system, the so-called IL-1 family, has been shown to play an important role in many of these diseases by regulating the body’s immune responses.
Professor Charles A. Dinarello from University of Colorado Denver is also an honorary doctor at Aarhus University. He is an expert in regulation and transmission of these cytokines. He is primarily known for discovering the important cytokine IL-1(-?), which plays an important role in countless diseases. In collaboration with Charles Dinarello, the Danish researchers have investigated a more efficient way of reducing the effect of the IL-1 family and in this way improve treatment of chronic inflammatory diseases.
Previous research has often focused on blocking a single cytokine or signaling pathway at a time. However, many diseases and sequela are driven by more than one cytokine. This has caused researchers to wonder if it could be possible to block more important signaling pathways of the IL-1 family at the same time, and in this way make it possible to develop better treatments. The researchers try to find a broader anti-inflammatory treatment impacting several important cytokines at the same time, but also trying to avoid that this causes unintended side-effects.
In this study, the researchers have investigated if a receptor (IL-1R3), which is not just involved in the signaling of one but six different inflammatory cytokines in the IL-1 family, could be a possible target in the treatment of chronic inflammatory disease. Using an antibody to block the effect of IL-1R3, it was possible for the researchers to investigate the effects in both studies on cells and mice.
In this way, researchers could study some of the consequences of the blocking of this receptor on the immune system. At the same time, the researchers specifically studied the effect of blocking IL-1R3 in mice with either gout, acute allergic inflammation (asthma) or psoriasis.
– The experiments showed that it was possible to effectively block the receptor and reduce manifestation of diseases, which underlines the potentials in our new approach, says MD and PhD Jesper Falkesgaard Højen.
– Even though new questions arise as a consequences of these results, we have managed to describe a new and effective approach to block IL-1 family driven inflammation, and in this way we have possibly contributed with a new direction to study and treat chronic inflammatory conditions driven by the IL-1 family.
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Parenting Beyond the Headlines Podcast #32: Talking about PANS, PANDAS and Autoimmune Encephalitison February 1, 2020 at 6:50 am
In this installment, they talk to Dr. Roseann Capanna-Hodge, author of Brain Under Attack, A Resource for Parents and Caregivers of Children with PANS, PANDAS and Autoimmune Encephalitis. These ...
- Former Jets player finds healing of music to help with autoimmune diseaseon January 31, 2020 at 10:27 am
A former Jets player who was diagnosed with a life-threatening illness has found the power of music to help him heal.
- Autoimmune Disease Diagnostic Market Forecasts,...on January 31, 2020 at 12:14 am
Dublin, Jan. 31, 2020 (GLOBE NEWSWIRE) -- The "Autoimmune Disease Diagnostic Market, by Disease, Tests Type, Regions, Global Forecast" report has been added to ResearchAndMarkets.com's offering. The ...
- ChemoCentryx: An Intriguing Rare Disease Player In 2020on January 30, 2020 at 12:31 pm
Today, we will study why ChemoCentryx (CCXI) is a promising investment opportunity in 2020. ChemoCentryx is a clinical-stage biopharmaceutical company focused on developing innovative oral therapies ...
- Selenium in thyroid disorders — essential knowledge for clinicianson January 30, 2020 at 9:23 am
Adverse health effects have been observed at both extremes of intake, with a narrow optimum range. Epidemiological studies have linked an increased risk of autoimmune thyroiditis, Graves disease and ...
- Autoimmune Drugs Market Survey Report 2019 Along with Statistics, Forecasts till 2025on January 29, 2020 at 12:30 pm
The Autoimmune Drugs Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2019-2025. The Autoimmune Drugs market report is a valuable source of data for business ...
- Could a bacteria-stuffed pill cure autoimmune diseases?on January 29, 2020 at 7:16 am
“Genetics was not going to explain this difference,” says Silverman. The revelation launched him on a decades-long quest to seek out other factors that drive the puzzling autoimmune disease.
- Global Autoimmune Treatment Market is Expected to Reach USD 7.95 Billion by 2025 : Fior Marketson January 27, 2020 at 4:22 pm
Newark, NJ, Jan. 27, 2020 -- As per the report published by Fior Markets, the global autoimmune treatment market is expected to grow from USD 3.28 Billion in 2017 to USD 7.95.
- Quench Bio to Tackle Inflammatory Diseases With $50 Millionon January 26, 2020 at 11:11 pm
Biotechnology companies are developing new ways to treat inflammation in autoimmune disorders and other diseases where inflammation plays important roles. Cambridge, Mass.-based Quench sees potential ...
- The Foods To Eat and Avoid If You Have an Autoimmune Diseaseon January 24, 2020 at 11:44 pm
If you're someone who battles an autoimmune disease, you know that many of them come with uncomfortable symptoms that often have a negative effect on your daily life. While there are many types of ...
via Bing News